Despite the fact that the MUC1 level in the HER2(+) subgroup is maximally reduced, we observed relative increases in advanced breast cancer stages, as well as in cases of low cell differentiation and high proliferative activity index. The gene discussed is MUC1; the disease is breast cancer.